Lowering Blood Pressure with the Combination of a Sodium-Glucose Cotransporter 2 Inhibitor and a Glucagon-like Peptide-1 Receptor Agonist in Type 2 Diabetic Patients: A Clinical Evidence
2018 ◽
Vol 25
(4)
◽
pp. 417-420
◽
2015 ◽
Vol 30
(suppl_3)
◽
pp. iii536-iii536
2016 ◽
Vol 31
(suppl_1)
◽
pp. i487-i487
2020 ◽
Vol 19
(10)
◽
pp. 2213-2217
2013 ◽
Vol 231
(1)
◽
pp. 57-61
◽
2001 ◽
Vol 86
(8)
◽
pp. 3717-3723
◽
2014 ◽
Vol 38
(2)
◽
pp. 143-147
◽
1998 ◽
Vol 15
(6)
◽
pp. 485-491
◽